for what its worth, updated charts representing revenue and staff costs.
![]()
and tables of the numbers
last quarter shows 3% increase in staff cost and 15% increase in revenue.
Column 1 Column 2 Column 3 0 month income staff cost 1 Sep-11 % change 2 Dec-11 -6% 12% 3 Mar-12 7% 12% 4 Jun-12 15% 30% 5 Sep-12 -14% -30% 6 Dec-12 22% 29% 7 Mar-13 -18% -2% 8 Jun-13 26% 29% 9 Sep-13 6% 6% 10 Dec-13 -11% 46% 11 Mar-14 -13% 7% 12 Jun-14 17% 60% 13 Sep-14 15% 3%
lets hope this continues.
only 91 days till the next Q report!!!!!!!!!
- Forums
- ASX - By Stock
- AVR
- What do you want from the Quarterly
What do you want from the Quarterly, page-43
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 681 | $17.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 681 | 17.900 |
1 | 1 | 17.800 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
18.250 | 100 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online